Signaturefd, LLC Allogene Therapeutics, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 2,201 shares of ALLO stock, worth $4,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,201

Previous 601 266.22%

Holding current value

$4,996

Previous $1,000 500.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$2.08 - $3.5 $3,328 - $5,600	1,600 Added 266.22%	2,201 $6,000
Q2 2024 Jul 29, 2024	SELL	$2.23 - $4.38 $8,155 - $16,017	-3,657 Reduced 85.89%	601 $1,000
Q1 2024 May 03, 2024	BUY	$2.92 - $5.63 $309 - $596	106 Added 2.55%	4,258 $19,000
Q4 2023 Jan 31, 2024	SELL	$2.28 - $3.5 $4,099 - $6,293	-1,798 Reduced 30.22%	4,152 $13,000
Q3 2023 Nov 03, 2023	BUY	$3.17 - $5.96 $6,466 - $12,158	2,040 Added 52.17%	5,950 $18,000
Q2 2023 Aug 01, 2023	BUY	$4.53 - $6.74 $2,378 - $3,538	525 Added 15.51%	3,910 $19,000
Q1 2023 Apr 28, 2023	BUY	$4.92 - $8.21 $13,859 - $23,127	2,817 Added 495.95%	3,385 $16,000
Q4 2022 Jan 27, 2023	SELL	$5.62 - $11.11 $11,245 - $22,231	-2,001 Reduced 77.89%	568 $3,000
Q2 2022 Aug 10, 2022	BUY	$6.78 - $12.28 $11,587 - $20,986	1,709 Added 198.72%	2,569 $29,000
Q1 2022 May 02, 2022	BUY	$7.65 - $15.29 $6,357 - $12,705	831 Added 2865.52%	860 $8,000
Q4 2021 Jan 25, 2022	SELL	$13.13 - $24.52 $932 - $1,740	-71 Reduced 71.0%	29 $0
Q3 2021 Oct 28, 2021	BUY	$21.01 - $27.64 $1,470 - $1,934	70 Added 233.33%	100 $3,000
Q2 2021 Jul 26, 2021	BUY	$23.49 - $35.8 $70 - $107	3 Added 11.11%	30 $1,000
Q1 2021 Apr 30, 2021	BUY	$25.79 - $39.02 $696 - $1,053	27 New	27 $1,000
Q4 2020 Feb 11, 2021	SELL	$25.24 - $43.45 $1,060 - $1,824	-42 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$32.38 - $44.96 $1,359 - $1,888	42 New	42 $2,000
Q2 2020 Jul 30, 2020	SELL	$18.39 - $54.04 $2,427 - $7,133	-132 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$18.22 - $28.25 $2,405 - $3,729	132 New	132 $3,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account